Omega Healthcare Investors, Inc. While talking about Performance of the Stock, Omega Healthcare Investors Inc. now has a Weekly performance of -4.86%, monthly performance percentage is -16.77 percent, Quarterly performance is -13.46 percent, 6 months performance shows a percent value of -19.47% and Yearly Performance is -5.6 percent. The stock was bought at an average cost of $27.38 per share, with a total value of $273,800.00. (OHI) has a market cap of $5.36 billion and over the last 12 months, Omega Healthcare Investors, Inc.
Several other institutional investors have also sold shares of the company. Vanguard Group Inc. grew its position in Omega Healthcare Investors by 2.3% during the 2nd quarter. During the same quarter previous year, the business posted $1.16 earnings per share. Bronfman E.L. Rothschild L.P. raised its position in Omega Healthcare Investors by 167.7% in the 2nd quarter. The value of the investment in (OHI) decreased from $6,466,000 to $6,259,000 a change of $207,000 quarter to quarter. State Street Corp boosted its holdings in shares of Omega Healthcare Investors by 4.3% in the second quarter.
November 1 investment analysts at SunTrust Banks made no change to the stock rating of "Hold" targeting a price of $30.00. That's a potential 9.89 increase relative to where Omega Healthcare Investors, Inc. BidaskClub downgraded Omega Healthcare Investors from a "hold" rating to a "sell" rating in a research report on Saturday, August 5th. Finally, TheStreet downgraded Omega Healthcare Investors from a "b-" rating to a "c" rating in a research report on Monday, October 30th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and two have assigned a buy rating to the stock. Cantor Fitzgerald reiterated a "neutral" rating and set a $75.00 target price on shares of National Health Investors in a research note on Tuesday, February 21st.
TRADEMARK VIOLATION NOTICE: "National Health Investors (NHI) Earning Somewhat Favorable Press Coverage, Report Finds" was reported by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this piece on another website, it was copied illegally and reposted in violation of US and global trademark and copyright legislation. The legal version of this report can be read at https://www.thelincolnianonline.com/2017/11/22/omega-healthcare-investors-inc-ohi-position-increased-by-pacer-advisors-inc.html. Further, company shares have been seen trading 0.12% off of the 52 week high and 37.64% away from the 52 week low. The average 1-year price target for (UNH) reveals an average price target of $225.95 per share. Following the completion of the transaction, the director now directly owns 903,895 shares in the company, valued at $25,525,994.80. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink.
In related news, Director Bernard J. Korman acquired 100,000 shares of the stock in a transaction dated Tuesday, October 31st. National Health Investors has a 52-week low of $68.75 and a 52-week high of $81.21. The company had a trading volume of 2,535,108 shares, compared to its average volume of 2,167,157. The company has a debt-to-equity ratio of 0.84, a current ratio of 12.72 and a quick ratio of 12.72. The company operates in the Real Estate sector with a market capitalization of 5.3 Million. Omega Healthcare Investors, Inc. Shareholders of record on Friday, December 29th will be given a dividend of $0.95 per share. ValuEngine upgraded shares of National Health Investors from a "hold" rating to a "buy" rating in a research report on Friday, November 10th. This represents a $3.80 annualized dividend and a yield of 4.84%. Finally, Mizuho restated a "hold" rating and issued a $82.00 price objective on shares of National Health Investors in a research report on Wednesday, October 4th.
Recent insider trends for Omega Healthcare Investors, Inc.
- Watch film before opposing it, says Union Minister over Padmavati row
- On-trade gives cautious welcome to business rates changes
- Claude Puel: 'Leicester City must be careful against West Ham United'
- Enterprise Products Partners LP (EPD) Stake Decreased by Bessemer Group Inc
- Alexion Pharmaceuticals (NASDAQ:ALXN) Earns Media Sentiment Score of 0.17
- Volvo XC40 production begins in Belgium
- US Bancorp (NYSE:USB) Ducks Under The Trend Line
- What Do Analysts Say About Netflix, Inc. (NFLX)
- The Brokers Issue Forecasts for Abbott Laboratories' Q1 2017 Earnings (ABT)
- Under Armour (UAA) Is It Worthy for Investors?